BeiGene Ltd ADR’s recently made public that its Affiliate 667, L.P. acquired Company’s shares for reported $16.13 million on Dec 09 ’24. In the deal valued at $187.27 per share,86,110 shares were bought.
Then, Baker Brothers Life Sciences, bought 950,907 shares, generating $178,074,395 in total proceeds.
Before that, HHLR ADVISORS, LTD. sold 17,842,500 shares. BeiGene Ltd ADR shares valued at $3,568,500,000 were divested by the 10% Owner at a price of $200.00 per share. As a result of the transaction, HHLR ADVISORS, LTD. now holds 125,045,741 shares, worth roughly $25.96 billion.
A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in mid September with a ‘”a Mkt outperform”‘ rating. Macquarie started covering the stock on September 12, 2023. It rated BGNE as “an Outperform”.
Price Performance Review of BGNE
On Monday, BeiGene Ltd ADR [NASDAQ:BGNE] saw its stock jump 0.97% to $207.62. Over the last five days, the stock has gained 0.91%. BeiGene Ltd ADR shares have risen nearly 15.11% since the year began. Nevertheless, the stocks have risen 15.76% over the past one year. While a 52-week high of $248.16 was reached on 10/04/24, a 52-week low of $126.97 was recorded on 04/19/24. SMA at 50 days reached $211.85, while 200 days put it at $177.67.
Levels Of Support And Resistance For BGNE Stock
The 24-hour chart illustrates a support level at 203.80, which if violated will result in even more drops to 199.99. On the upside, there is a resistance level at 211.22. A further resistance level may holdings at 214.82. The Relative Strength Index (RSI) on the 14-day chart is 54.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.22, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 30.16%. Stochastics %K at 62.88% indicates the stock is a holding.
How much short interest is there in BeiGene Ltd ADR?
A steep rise in short interest was recorded in BeiGene Ltd ADR stocks on 2024-11-15, dropping by -0.51 million shares to a total of 1.0 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 1.51 million shares. There was a decline of -51.12%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 17, 2023 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $287 price target.
